S&P 500 7,577.93 −1.85%
Nasdaq 25,390.22 −3.03%
S&P/TSX 35,512.81 −2.03%
Apple 346.76 −0.62%
Nvidia 203.12 −4.93%
Microsoft 521.15 −1.70%
Shopify 217.26 −7.03%
Royal Bank 283.04 −1.79%
CAD/USD 0.7169 +0.27%
LIVE · 13:30 ET
Market ClerkRecap
Fri Oct 30 · markets open3 signals today167 insider buys this week · $10.1BCIRO short report next: Oct 31The week ahead

TLX

Telix Pharmaceuticals Ltd
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
9.15
−0.36 −3.84%
USD · close Oct 30

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose TLX in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
No 13D or 13G filing on TLX in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch TLX. Know when insiders buy.
One email the day a filing lands. Free.